Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Feb-24 4:04 PM View:  | Syndax Pharmaceuticals Inc (SNDX) | 07-Feb-24 | Grant | 34,000 | -- | -- | 32% 107.76K to 141.76K | |
| 03-Feb-23 4:57 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 02-Feb-23 | Grant | 32,000 | -- | -- | 42% 75.76K to 107.76K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 16-Sep-22 | Option Exercise | 11,975 | $6.34 | $75,878.70 | 16% 75.76K to 87.74K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 16-Sep-22 | Planned Option Sale | 11,975 | $23.43 | $280,607.00 | (14%) 87.74K to 75.76K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 15-Sep-22 | Option Exercise | 66,840 | $6.32 | $422,429.00 | 88% 75.76K to 142.6K | |
| 16-Sep-22 5:34 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 15-Sep-22 | Planned Option Sale | 66,840 | $24.20 | $1,617,380.00 | (47%) 142.6K to 75.76K | |
| 03-Feb-22 5:30 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 02-Feb-22 | Grant | 32,000 | -- | -- | 73% 43.76K to 75.76K | |
| 06-Oct-21 4:09 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 05-Oct-21 | Acquisition (other) | 463 | -- | -- | 1% 43.3K to 43.76K | |
| 22-Apr-21 5:06 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 22-Apr-21 | Market Purchase | 13,967 | $14.11 | $197,077.00 | 48% 29.33K to 43.3K | 5% |
| 05-Feb-21 4:18 PM View: | Syndax Pharmaceuticals Inc (SNDX) | 03-Feb-21 | Grant | 29,333 | -- | -- | 100% 0 to 29.33K | |
| 07-May-19 9:02 PM View: | HepaLife Technologies Inc. (ALQA) | 03-May-19 | Grant | 85,254 | -- | -- | 100% 0 to 85.25K | |
| 14-Feb-14 8:00 PM View: | Avanir Pharmaceuticals (AVNR) | 12-Feb-14 | Grant | 28,900 | -- | -- | 9% 307.49K to 336.39K | |
| 19-Feb-13 5:04 PM View: | Avanir Pharmaceuticals (AVNR) | 14-Feb-13 | Grant | 38,900 | -- | -- | 14% 268.59K to 307.49K | |
| 17-Feb-12 5:11 PM View: | Avanir Pharmaceuticals (AVNR) | 16-Feb-12 | Grant | 30,000 | -- | -- | 13% 238.59K to 268.59K | |
| 10-Feb-11 5:24 PM View: | Avanir Pharmaceuticals (AVNR) | 08-Feb-11 | Grant | 30,000 | -- | -- | 14% 208.59K to 238.59K | |
| 22-Feb-10 3:40 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Feb-10 | Grant | 40,000 | -- | -- | 24% 168.59K to 208.59K | |
| 20-Feb-09 8:29 PM View: | Avanir Pharmaceuticals (AVNR) | 19-Feb-09 | Grant | 60,000 | -- | -- | 55% 108.59K to 168.59K | |
| 25-Feb-08 8:19 PM View: | Avanir Pharmaceuticals (AVNR) | 21-Feb-08 | Grant | 56,911 | -- | -- | 110% 51.68K to 108.59K | |
| 05-Mar-07 1:06 PM View: | Avanir Pharmaceuticals (AVNR) | 01-Mar-07 | Grant | 44,248 | -- | -- | 595% 7.43K to 51.68K | |
| 02-Jun-06 5:17 PM View: | Avanir Pharmaceuticals (AVNR) | 31-May-06 | Market Purchase | 1,000 | $9.90 | $9,902.00 | 16% 6.43K to 7.43K | 16% |
| 23-May-06 4:58 PM View: | DOV Pharmaceutical Inc. (DOVP.OB) | 22-May-06 | Grant | 8,333 | -- | -- | 100% 0 to 8.33K | |
| 15-Feb-06 5:45 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Feb-06 | Grant | 6,435 | -- | -- | 100% 0 to 6.43K |